Veri MedTech Sets $4.00 IPO Price for 3.75M Shares, Seeks NASDAQ Uplisting
VRHID has more than doubled off its 52-week low of $0.335.
Summary
Veri MedTech Holdings priced its IPO at $4.00 per share for 3.75 million shares, seeking to raise $15 million gross and uplist to NASDAQ. The company faces a going concern warning with significant accumulated deficits, making this offering critical for survival.
Updates
· SEC S-1/A — Amendment discloses material weakness and only $6,146 in cash; NASDAQ listing approval is a condition to closing.
Key Events · Financing and Capital Events · VRHID
-
IPO Priced at $4.00 Per Share
Company offering 3,750,000 shares at $4.00 each for gross proceeds of $15,000,000, with net proceeds of approximately $11,948,000 after underwriting discounts and expenses.
-
NASDAQ Uplisting Contingent on Approval
Offering is contingent on NASDAQ Capital Market approval under symbol VRHI. If not approved, the offering will be terminated. Stock currently trades on OTCID at $5.00 per share.
-
Going Concern Warning
As of June 30, 2026, stockholders' deficit of $2,732,874, accumulated deficit of $5,337,798, and working capital deficit of $2,457,354. Company states substantial doubt about ability to continue as going concern.
-
Reverse Stock Split Completed
1-for-2.5 reverse stock split effected September 2, 2026, reducing outstanding shares to 8,000,004. All share and per-share data retroactively adjusted.
Analysis · VRHID · Technology
Veri MedTech Holdings has finalized terms for its initial public offering, pricing 3.75 million shares at $4.00 each for gross proceeds of $15 million. The offering is contingent on NASDAQ Capital Market approval, and the company is currently quoted on OTCID at $5.00 per share. The deal includes a 7% underwriting discount, a 2% non-accountable expense allowance, and underwriter warrants for 5% of shares sold at a $4.80 exercise price. The company's financials show a going concern warning with a stockholders' deficit of $2.73 million and accumulated deficit of $5.34 million as of June 30, 2026, making this capital raise critical for continued operations. A 1-for-2.5 reverse stock split was effected on September 2, 2026, reducing outstanding shares to 8 million. The offering would increase shares outstanding by approximately 47% to 11.75 million, with existing shareholders experiencing immediate dilution of $3.22 per share based on the $4.00 offering price.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VRHID was trading at $5.00 on OTC in the Technology sector, with a market capitalization of approximately $40M. The 52-week trading range was $0.34 to $6.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.